Your browser doesn't support javascript.
loading
[Value of dynamic MRI in monitoring the microenvironmental changes of anti-vascular therapy in a xenograft model].
Liang, J Y; Xiao, Z Y; Zhang, D; Ma, M J; Huang, J X; Shi, C Z; Luo, L P.
Afiliación
  • Liang JY; Medical Imaging Center, the First Affiliated Hospital of Jinan University, Guangzhou 510632, China.
  • Xiao ZY; Institute of Molecular and Functional Imaging, the First Affiliated Hospital of Jinan University, Guangzhou 510632, China.
  • Zhang D; Medical Imaging Center, the First Affiliated Hospital of Jinan University, Guangzhou 510632, China.
  • Ma MJ; Medical Imaging Center, the First Affiliated Hospital of Jinan University, Guangzhou 510632, China.
  • Huang JX; Medical Imaging Center, the First Affiliated Hospital of Jinan University, Guangzhou 510632, China.
  • Shi CZ; Medical Imaging Center, the First Affiliated Hospital of Jinan University, Guangzhou 510632, China.
  • Luo LP; Medical Imaging Center, the First Affiliated Hospital of Jinan University, Guangzhou 510632, China.
Zhonghua Yi Xue Za Zhi ; 100(1): 51-56, 2020 Jan 07.
Article en Zh | MEDLINE | ID: mdl-31914559
ABSTRACT

Objective:

To explore the feasibility of dynamic-enhanced magnetic resonance imaging (DCE-MRI) and blood oxygen level-dependent MRI (BOLD-MRI) in assessing the hemodynamics and tumor aggressiveness during treatment.

Methods:

The colon cancer xenograft model was established in BALB/C nude mice with HCT116 cell line. Sixteen nude mice were randomly divided into treatment and control groups (aged 6 to 8 weeks, weighted 15 to 18 g, Certificate No. 11400700325797), which were treated with bevacizumab and saline by intraperitoneal injection on the 1st, 4th, 7th, 10th and 13th day. DCE-MRI and BOLD-MRI were performed before and on the 3th, 6th, 9th, 12th, and 15th day after treatment. The vascular maturity and microenvironment hypoxia were confirmed by pathology.

Results:

The tumor volume of treatment group was significantly smaller than that of control group after 15 days ((712±43) vs (1 051±112) mm(3),P<0.01).The measurements of K(trans) were (0.135±0.005),(0.147±0.006),(0.175±0.009),(0.161±0.006), (0.140±0.005),(0.116±0.008)/min (F=81.386, P<0.01); K(ep) were (0.788±0.030),(0.804±0.036),(0.983±0.059), (1.105±0.091),(0.840±0.047),(0.786±0.041)/min(F=45.901,P<0.01);Ve were (0.652±0.006), (0.559±0.026), (0.466±0.016), (0.286±0.027), (0.363±0.020), (0.246±0.033) (F=384.290, P<0.01) and R2* values were (24.813±0.961), (24.675±1.070), (21.425±1.371), (17.850±0.885), (24.613±0.640), (27.013±0.734)/s (F=89.323, P<0.01) showed different trends with time in the treatment group, and the differences were statistically significant. The K(trans) values and tumor vessel maturity index (VMI) were higher than baseline values during 3-12 d after treatment. CD31 positive staining rate and VMI had the strongest correlations with K(trans) values (r=0.854 and 0.795), followed by AUC(180) (r=0.750 and 0.808), Ve (r=0.744 and 0.712) and K(ep) values (r=0.729 and 0.758), all P<0.05. R2* value positively correlated with the positive staining rate of HIF-1α and fibronectin (r=0.810 and 0.816), all P<0.05.

Conclusion:

DCE-MRI and BOLD-MRI are adequate to observe the tumor perfusion and hypoxia during anti-vascular treatment, and the R2* value can predict the tumor metastatic potential during the process of vascular normalization.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Imagen por Resonancia Magnética / Medios de Contraste Tipo de estudio: Prognostic_studies Límite: Animals Idioma: Zh Revista: Zhonghua Yi Xue Za Zhi Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Imagen por Resonancia Magnética / Medios de Contraste Tipo de estudio: Prognostic_studies Límite: Animals Idioma: Zh Revista: Zhonghua Yi Xue Za Zhi Año: 2020 Tipo del documento: Article País de afiliación: China